{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:05:05Z","timestamp":1788923105929,"version":"build-2803163510"},"reference-count":44,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> Intrathecally delivered baclofen has been used as a treatment for severe spasticity since 1984. Despite this, there are uncertainties surrounding the benefits of treatment and the costs involved. The authors assessed the evidence of benefits and identified costs and the cost\/benefit ratio for continuous intrathecal baclofen infusion in the treatment of severe spasticity.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> A systematic literature review was conducted to estimate the effect of continuous intrathecal baclofen infusion on function and quality-of-life (QOL) measures in patients with severe spasticity. Outcomes were related to standard QOL scores to estimate potential gains in quality-adjusted life years (QALYs). Information on the costs of continuous intrathecal baclofen infusion was obtained from hospitals in the United Kingdom. This information was combined to estimate the cost\/benefit ratio for the use of continuous intrathecal baclofen infusion in patients with different levels of disability from severe spasticity.<\/jats:p>\n<jats:p content-type=\"fine-print\">Studies indicate that bedbound patients are likely to improve their mobility and become able to sit out of bed. Patients with severe spasm-related pain are likely to have major improvement or complete resolution of this pain. Many other benefits are also reported. Such benefits are related to costs per QALY in the range of \u00a36900 to \u00a312,800 ($10,550\u2013$19,570 US).<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> In carefully selected patients who have not responded to less invasive treatments, continuous intrathecal baclofen infusion is likely to lead to worthwhile functional benefits. Continuous intrathecal baclofen infusion has an acceptable cost\/benefit ratio compared with other interventions that are funded by the health service.<\/jats:p>","DOI":"10.3171\/jns.2002.96.6.1052","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:44:46Z","timestamp":1242236686000},"page":"1052-1057","source":"Crossref","is-referenced-by-count":88,"title":["Functional benefits and cost\/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity"],"prefix":"10.3171","volume":"96","author":[{"given":"Fiona C.","family":"Sampson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Collett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0003-9993(94)90337-9","article-title":"Intrathecal baclofen for treatment of intractable spinal spasticity.","volume":"75","author":"Abel","year":"1994"},{"key":"b2","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1001\/jama.1993.03510200081036","article-title":"Continuous intrathecal baclofen infusion for spasticity of cerebral origin.","volume":"270","author":"Albright","year":"1993"},{"key":"b3","series-title":"Bandolier","first-page":"1","article-title":"Pressure sores: five reviews & an RCT.","volume":"6","year":"1994"},{"key":"b4","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0003-9993(96)90217-8","article-title":"Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up.","volume":"77","author":"Azouvi","year":"1996"},{"key":"b5","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s004150050067","article-title":"Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury.","volume":"244","author":"Becker","year":"1997"},{"key":"b6","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S031716710003986X","article-title":"Long-term intrathecal baclofen therapy in patients with intractable spasticity.","volume":"22","author":"Becker","year":"1995"},{"key":"b7","series-title":"J Health Serv Res Policy","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/135581969900400310","article-title":"A review of the use of health status measures in economic evaluation.","volume":"4","author":"Brazier","year":"1999"},{"key":"b8","series-title":"Acta Neurochir Suppl","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-7091-9029-6_9","article-title":"Use of intrathecal baclofen administered by programmable infusion pumps in resistant spasticity.","volume":"46","author":"Broseta","year":"1989"},{"key":"b9","series-title":"A Therapeutic and Economic Assessment of Betaferon in Multiple Sclerosis.","author":"Brown","year":"1996"},{"key":"b10","series-title":"Stereotact Funct Neurosurg","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000098605","article-title":"Management of intractable spasticity of supraspinal origin by chronic cervical intrathecal infusion of baclofen.","volume":"62","author":"Concalves","year":"1994"},{"key":"b11","series-title":"Int J Rehabil Health","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF02766064","article-title":"Intrathecal baclofen for severe spasticity: a meta-analysis.","volume":"3","author":"Creedon","year":"1997"},{"key":"b12","series-title":"Soc Sci Med","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0277-9536(93)90315-U","article-title":"Cost-effectiveness league tables: more harm than good?","volume":"37","author":"Drummond","year":"1993"},{"key":"b13","series-title":"Health Policy","first-page":"199","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life.","volume":"16","year":"1990"},{"key":"b14","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000121223","article-title":"Effect on ambulation of continuous intrathecal baclofen infusion.","volume":"27","author":"Gerszten","year":"1997"},{"key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3171\/jns.1998.88.6.1009","article-title":"Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy.","volume":"88","author":"Gerszten","year":"1998"},{"key":"b16","series-title":"Ann Intern Med","doi-asserted-by":"publisher","first-page":"152","DOI":"10.7326\/0003-4819-126-2-199701150-00011","article-title":"The role of medical necessity and cost-effectiveness in making medical decisions.","volume":"126","author":"Glassman","year":"1997"},{"key":"b17","series-title":"Med Decis Making","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/0272989X0002000310","article-title":"Willingness to pay for a quality-adjusted life year: in search of a standard.","volume":"20","author":"Hirth","year":"2000"},{"key":"b18","series-title":"Can Med Assoc J","first-page":"473","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.","volume":"146","author":"Laupacis","year":"1992"},{"key":"b19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3171\/jns.1990.72.3.0393","article-title":"Chronic intrathecal baclofen administration for control of severe spasticity.","volume":"72","author":"Lazorthes","year":"1990"},{"key":"b20","series-title":"J Pain Symptom Manage","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0885-3924(96)00152-2","article-title":"Effects of intrathecal baclofen on chronic spinal cord injury pain.","volume":"12","author":"Loubser","year":"1996"},{"key":"b21","series-title":"Paraplegia","first-page":"48","article-title":"Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury.","volume":"29","author":"Loubser","year":"1991"},{"key":"b22","series-title":"Br J Hosp Med","first-page":"262","article-title":"Intrathecal baclofen in severe spasticity.","volume":"49","author":"McLean","year":"1993"},{"key":"b23","series-title":"Acta Neurochir Suppl","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-7091-9419-5_5","article-title":"Long-term clinical, electrophysiological and urodynamic effects of chronic intrathecal baclofen infusion for treatment of spinal spasticity.","volume":"64","author":"Mertens","year":"1995"},{"key":"b24","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp.63.2.204","article-title":"Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity.","volume":"63","author":"Middel","year":"1997"},{"key":"b25","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1017\/S0317167100040452","article-title":"Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions.","volume":"22","author":"Nance","year":"1995"},{"key":"b26","series-title":"J Urol","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-5347(17)38673-1","article-title":"Effect of intrathecal baclofen on bladder and sphincter function.","volume":"142","author":"Nanninga","year":"1989"},{"key":"b27","series-title":"Beta Interferons (1a and 1b) in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.","author":"Nicholson","year":"1999"},{"key":"b28","series-title":"J Neuro Rehab","first-page":"159","article-title":"Functional outcome and clinical significance of long-term intrathecal baclofen therapy for severe spasticity.","volume":"10","author":"Ochs","year":"1996"},{"key":"b29","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3171\/jns.1996.85.3.0452","article-title":"Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity.","volume":"85","author":"Ordia","year":"1996"},{"key":"b30","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0003-9993(21)01642-7","article-title":"Functional outcome after delivery of intrathecal baclofen.","volume":"70","author":"Parke","year":"1989"},{"key":"b31","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jnnp.57.5.582","article-title":"Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump.","volume":"57","author":"Patterson","year":"1994"},{"key":"b32","series-title":"Lancet","first-page":"125","article-title":"Continuous intrathecal baclofen for severe spasticity.","volume":"2","author":"Penn","year":"1985"},{"key":"b33","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3171\/jns.1987.66.2.0181","article-title":"Long-term intrathecal baclofen infusion for treatment of spasticity.","volume":"66","author":"Penn","year":"1987"},{"key":"b34","series-title":"Pharmacoeconomics","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2165\/00019053-199915040-00007","article-title":"Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.","volume":"15","author":"Postma","year":"1999"},{"key":"b35","series-title":"Purchasing Power Parities. Comparative Price Levels."},{"key":"b36","series-title":"Acta Neurochir","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/BF01400686","article-title":"Intraspinal baclofen in the treatment of severe spasticity and spasms.","volume":"110","author":"Sahuquillo","year":"1991"},{"key":"b37","series-title":"Guidance Notes for Purchasers 00\/01.","article-title":"The effectiveness of intrathecal baclofen in the management of patients with severe spasticity","author":"Sampson","year":"2000"},{"key":"b38","series-title":"Cochrane Library","article-title":"Anti-spasticity agents for multiple sclerosis.","volume":"1","author":"Shakespeare","year":"1998"},{"key":"b39","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000120911","article-title":"Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy.","volume":"22","author":"Steinbok","year":"1995"},{"key":"b40","series-title":"Clin Exp Neurol","first-page":"244","article-title":"Intrathecal baclofen for severe spasticity: five years experience.","volume":"28","author":"Stewart-Wynne","year":"1991"},{"key":"b41","series-title":"Cochrane Library","article-title":"Pharmacological interventions for spasticity following spinal cord injury.","volume":"1","author":"Taricco","year":"1998"},{"key":"b42","series-title":"Risk Anal","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1539-6924.1995.tb00330.x","article-title":"Five hundred life-saving interventions and their cost-effectiveness.","volume":"15","author":"Tengs","year":"1995"},{"key":"b43","series-title":"Local-Spinal Therapy of Spasticity.","first-page":"255","article-title":"Surgical treatment of spasticity\u2014a review","author":"Zierski","year":"1988"},{"key":"b44","series-title":"Acta Neurochir Suppl","first-page":"94","article-title":"Implanted pump systems for treatment of spasticity.","volume":"43","author":"Zierski","year":"1988"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/96\/6\/article-p1052.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/96\/6\/article-p1052.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/96\/6\/article-p1052.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:41:01Z","timestamp":1679866861000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/96\/6\/article-p1052.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":44,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/jns.2002.96.6.1052","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}